12 months from date of receipt / reconstitution, -20 °C as supplied
| 应用 | 稀释度 | 推荐种属 |
|---|---|---|
| WB | 1:1000 | Ms, Rt |
GLS2 is a mitochondrial phosphate-activated glutaminase that catalyzes the hydrolysis of glutamine to stoichiometric amounts of glutamate and ammonia. It plays an important role in the regulation of glutamine catabolism. It promotes mitochondrial respiration and increases ATP generation in cells by catalyzing the synthesis of glutamate and alpha-ketoglutarate. It also increases cellular anti-oxidant function via NADH and glutathione production. GLS2 has been implicated in various cancers. It is overexpressed in triple-negative basal-like breast cancer (TNBC) and metastatic lung cancer, and it confers radioresistance in advanced human cervical cancer cells. GLS2 may also reduce reactive oxygen species (ROS) levels by increasing the level of cellular reduced glutathione (GSH), NADH, or NADPH, suggesting a role in cancer metabolism.
WB result of GLS2 Rabbit pAb
Primary antibody: GLS2 Rabbit pAb at 1/1000 dilution
Lane 1: mouse spleen lysate 20 µg
Lane 2: mouse kidney lysate 20 µg
Lane 3: mouse liver lysate 20 µg
Negative control: mouse spleen lysate; mouse kidney lysate
Secondary antibody: Goat Anti-Rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution Predicted MW: 66 kDa
Observed MW: 60 kDa
WB result of GLS2 Rabbit pAb
Primary antibody: GLS2 Rabbit pAb at 1/1000 dilution
Lane 1: rabbit spleen lysate 20 µg
Lane 2: rat kidney lysate 20 µg
Lane 3: rat liver lysate 20 µg
Negative control: rabbit spleen lysate; rat kidney lysate
Secondary antibody: Goat Anti-Rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution Predicted MW: 66 kDa
Observed MW: 60 kDa
您现在的位置：